Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group

B. C. Tilley, P. D. Lyden, T. G. Brott, M. Lu, S. R. Levine and K. M. Welch
Division of Biostatistics and Research Epidemiology, Henry Ford Health Sciences Center, Case Western Reserve University, Detroit, Mich., USA. btilley1@biostat.hfh.edu

OBJECTIVE: To develop an approach for reducing time between emergency department (ED) admission and treatment in patients with acute ischemic stroke to meet the challenge of providing tissue plasminogen activator treatment within 180 minutes. DESIGN: An observational study. SETTING: Forty trial-affiliated hospitals, including 30 community hospitals. PARTICIPANTS: A total of 17,324 consecutive patients admitted to trial-affiliated hospital EDs within 24 hours of possible stroke, from January 1991 through October 1994. INTERVENTION: Appraisal of the process of triage, evaluation, diagnosis, and treatment by means of total quality improvement techniques in each hospital. Staff participating in the process identified sources of variation and modifications by flow charting the process. MAIN OUTCOME MEASURE: Time between ED admission and treatment with study medication. RESULTS: Total quality improvement methods identified hospital-specific process improvements. Many improvements were administrative, requiring no additional resources. More than 50% of screened patients arrived too late to be treated. Only 1268 patients were admitted between 0 and 125 minutes from stroke onset with no other trial exclusion criteria; 48% were treated. Of 243 patients admitted between 126 and 170 minutes from stroke onset with no exclusion criteria, 4% were treated. Mean time from ED admission to treatment was similar in teaching and community hospitals. CONCLUSIONS: Total quality improvement methods identified ED-specific sources of process variability and reduced time between ED admission and treatment. Therefore, these methods should be considered in developing and monitoring emergent stroke treatment protocols.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invited Article: Neurology and quality improvement: An introduction
Bever et al.
Neurology 2008;70:1636-1640.
FULL TEXT  

Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry
The Paul Coverdell Prototype Registries Writing Gr
Stroke 2005;36:1232-1240.
ABSTRACT | FULL TEXT  

Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review
Kwan et al.
QJM 2004;97:273-279.
ABSTRACT | FULL TEXT  

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Katzan et al.
Arch Neurol 2004;61:346-350.
ABSTRACT | FULL TEXT  

Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations
Stahl et al.
Radiology 2003;228:659-668.
ABSTRACT | FULL TEXT  

Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project
Morgenstern et al.
Stroke 2002;33:160-166.
ABSTRACT | FULL TEXT  

Graduating neurology residents' experience with IV tPA for acute stroke
Cucchiara and Kasner
Neurology 2001;57:1729-1730.
FULL TEXT  

Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals Editorial Comment
Reed et al.
Stroke 2001;32:1832-1840.
ABSTRACT | FULL TEXT  

Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler et al.
Neurology 2000;55:1649-1655.
ABSTRACT | FULL TEXT  

Recommendations for the Establishment of Primary Stroke Centers
Alberts et al.
JAMA 2000;283:3102-3109.
ABSTRACT | FULL TEXT  

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke
CMAJ 2000;162:1589-1593.
 

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: The Cleveland Area Experience
Katzan et al.
JAMA 2000;283:1151-1158.
ABSTRACT | FULL TEXT  

Treating Acute Stroke Patients With Intravenous tPA : The OSF Stroke Network Experience
Wang et al.
Stroke 2000;31:77-81.
ABSTRACT | FULL TEXT  

"Telestroke" : The Application of Telemedicine for Stroke
Levine and Gorman
Stroke 1999;30:464-469.
ABSTRACT | FULL TEXT  

Tissue-Type Plasminogen Activator
Pittman and Horowitz
Arch Neurol 1998;55:1377-1378.
FULL TEXT  

Timely and Appropriate Treatment of Acute Stroke: What's Missing From This Picture?
Fontanarosa and Winker
JAMA 1998;279:1307-1309.
FULL TEXT